<p>Fused bicyclic pyrimidine compounds having an amide-substituted pyridylamine group at C-4 of the pyrimidine of formula (I) ring are useftul in the treatment of conditions associated with HCV.</p>
申请公布号
CA2602294(C)
申请公布日期
2015.02.24
申请号
CA20062602294
申请日期
2006.03.27
申请人
TIBOTEC PHARMACEUTICALS LTD.
发明人
SIMMEN, KENNETH ALAN;CHAKRAVARTY, SARVAJIT;HART, BARRY;SURLERAUX, DOMINIQUE LOUIS NESTOR GHISIAN;LIN, TSE-I;LENZ, OLIVER;RABOISSON, PIERRE JEAN-MARIE BERNARD
